Kenneth Li - PRWeb Press Release Account Feed http://www.rsspad.com/rss2a/233824.xml Kenneth Li - Press Releases en xml@emediawire.com xml@emediawire.com 30 Tree of Life Adds Hearts&Minds Peanut Butter With Olive Oil and Omega-3 To Its Selection http://www.prweb.com/releases/2008/10/prweb1445964.htm Nation's leading natural product distributer adds Hearts&Minds Peanut Butter to inventory and increases availability. (PRWeb Oct 9, 2008)

Read the full story at http://www.prweb.com/releases/2008/10/prweb1445964.htm

]]> http://www.prweb.com/releases/2008/10/prweb1445964.htm New Sperm Micro-Manipulation and Isolation Technique May Increase Sexual Assault Convictions http://www.prweb.com/releases/2008/10/prweb1409334.htm "Sperm Picking" Technique Can Dramatically Speed Up the DNA Testing Process. (PRWeb Oct 2, 2008)

Read the full story at http://www.prweb.com/releases/2008/10/prweb1409334.htm

]]> http://www.prweb.com/releases/2008/10/prweb1409334.htm National Institute of Justice Grant Will Enable 200 Forensic Scientists to Receive Training at the College of Microscopy http://www.prweb.com/releases/2008/10/prweb1402854.htm National Institute of Justice Grant will enable 200 forensic scientists to receive free training at The McCrone Group's College of Microscopy. (PRWeb Oct 1, 2008)

Read the full story at http://www.prweb.com/releases/2008/10/prweb1402854.htm

]]> http://www.prweb.com/releases/2008/10/prweb1402854.htm Ash Stevens Presents Advantages of Barrier Isolation Technology for Handling Highly Potent Active Pharmaceutical Ingredients at Pharma Ed Conference http://www.prweb.com/releases/2008/05/prweb976704.htm Rebecca Ahn, an industry expert with Ash Stevens Inc. (ASI), today will present the advantages of barrier isolation technology over cleanroom suites in the safe and efficient manufacture of Busulfex® at PharmaEd's "Containment of Potent Compounds Conference" in Philadelphia. ASI is a full-service cGMP contractor that provides low-volume, high-value API (active pharmaceutical ingredients) to the pharmaceutical industry. (PRWeb May 29, 2008)

Read the full story at http://www.prweb.com/releases/2008/05/prweb976704.htm

]]> http://www.prweb.com/releases/2008/05/prweb976704.htm Ash Stevens Inc. CEO to Chair Session On Cancer Drug Development at American Association for Cancer Research Annual Meeting http://www.prweb.com/releases/2008/04/prweb849514.htm Ash Stevens Inc.™ (ASI) President and CEO Dr. Stephen Munk will chair an educational session for the Chemistry in Cancer Research Working Group (CICR) at the American Association for Cancer Research (AACR) annual meeting on Saturday, April 12 at the San Diego Convention Center. Dr. Munk's session will highlight the unique developmental challenges of safely manufacturing highly potent active pharmaceutical ingredients (APIs) used in cancer drugs. (PRWeb Apr 12, 2008)

Read the full story at http://www.prweb.com/releases/2008/04/prweb849514.htm

]]> http://www.prweb.com/releases/2008/04/prweb849514.htm Ash Stevens, INC. Invests In Riverview Facility http://www.prweb.com/releases/2008/02/prweb681944.htm ASI installed a new Bruker Biospin 400 MHz Avance III nuclear magnetic resonance (NMR) instrument as well as a third Rosenmund filter-dryer. The NMR will enable the company's chemists to rapidly obtain detailed analytical and structural information. The filter-dryer will be equipped with glove-box technology for handling potent and air sensitive cGMP APIs in a contained environment. (PRWeb Feb 8, 2008)

Read the full story at http://www.prweb.com/releases/2008/02/prweb681944.htm

]]> http://www.prweb.com/releases/2008/02/prweb681944.htm Cedarburg Pharmaceuticals Raises $3.5 Million in Series A-3 Financing http://www.prweb.com/releases/2007/02/prweb504648.htm Cedarburg Pharmaceuticals received $3.5 million in preferred stock financing. Investors included Sanders Morris Harris Group and Alfred Bader, founder of Aldrich Chemical. In addition, Cedarburg received European approval to market cancer pain relievers Fentanyl Base and Fentanyl Citrate. (PRWeb Feb 13, 2007)

Read the full story at http://www.prweb.com/releases/2007/02/prweb504648.htm

]]> http://www.prweb.com/releases/2007/02/prweb504648.htm